STARR KEVIN P

CIK 000119260324 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001192603

Recent Transactions

50 trades

Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-15+10,000→ 10,000 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-16+9,947→ 9,947 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2021-11-12$8.38/sh−1,900,000→ 1,148,780 total
Other
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2021-11-10−1,000,000→ 3,962,202 total
Other
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2021-09-22−1,000,000→ 4,962,202 total
Other
Jounce Therapeutics, Inc.
Common Stock
2021-09-15−1,750,000→ 2,697,829 total
Purchase
Sage Therapeutics, Inc.
Common Stock
2021-06-16$56.05/sh+17,842→ 320,659 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-10+10,000→ 10,000 total
Other
Jounce Therapeutics, Inc.
Common Stock
2021-06-10−1,500,000→ 4,447,829 total
Sale
Revolution Medicines, Inc.$RVMD
Common Stock
2021-06-04$30.23/sh−164,996→ 0 total
Sale
Revolution Medicines, Inc.$RVMD
Common Stock
2021-06-03$30.20/sh−378,117→ 164,996 total
Sale
Revolution Medicines, Inc.$RVMD
Common Stock
2021-05-26$30.53/sh−1,231,204→ 543,113 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2021-05-25$8.00/sh−552,520→ 5,947,829 total
Sale
Revolution Medicines, Inc.$RVMD
Common Stock
2021-05-25$30.93/sh−135,000→ 1,774,317 total
Other
Nurix Therapeutics, Inc.$NRIX
Common Stock
2021-05-06−1,085,784→ 3,422,549 total
Other
Jounce Therapeutics, Inc.
Common Stock
2021-03-11−1,250,000→ 6,500,349 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2021-03-01$11.75/sh−1,450,000→ 7,750,349 total
Other
Revolution Medicines, Inc.$RVMD
Common Stock
2021-02-24−1,500,000→ 5,524,031 total
Other
Nurix Therapeutics, Inc.$NRIX
Common Stock
2021-02-04−914,216→ 4,508,333 total
Sale
Relay Therapeutics, Inc.$RLAY
Common Stock
2021-01-14$41.00/sh−1,965,294→ 0 total
Sale
Relay Therapeutics, Inc.$RLAY
Common Stock
2021-01-13$44.73/sh−7,412→ 7,739,918 total
Sale
Relay Therapeutics, Inc.$RLAY
Common Stock
2021-01-13$44.00/sh−4,325→ 7,747,330 total
Sale
Relay Therapeutics, Inc.$RLAY
Common Stock
2021-01-13$44.73/sh−4,782→ 1,965,294 total
Sale
Relay Therapeutics, Inc.$RLAY
Common Stock
2021-01-13$42.12/sh−27,650→ 1,972,867 total
Sale
Relay Therapeutics, Inc.$RLAY
Common Stock
2021-01-13$42.12/sh−42,860→ 7,751,655 total
Sale
Relay Therapeutics, Inc.$RLAY
Common Stock
2021-01-13$40.01/sh−1,247,873→ 7,803,242 total
Sale
Relay Therapeutics, Inc.$RLAY
Common Stock
2021-01-13$41.08/sh−8,727→ 7,794,515 total
Sale
Relay Therapeutics, Inc.$RLAY
Common Stock
2021-01-13$44.00/sh−2,791→ 1,970,076 total
Sale
Relay Therapeutics, Inc.$RLAY
Common Stock
2021-01-13$41.08/sh−5,630→ 2,000,517 total
Sale
Relay Therapeutics, Inc.$RLAY
Common Stock
2021-01-13$40.01/sh−805,050→ 2,006,147 total
Sale
Relay Therapeutics, Inc.$RLAY
Common Stock
2021-01-12$40.00/sh−1,500,000→ 9,051,115 total
Other
Revolution Medicines, Inc.$RVMD
Common Stock
2020-12-02−1,000,000→ 7,024,031 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2020-11-19$7.00/sh−15,000→ 9,200,349 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2020-11-17$7.25/sh−15,000→ 9,215,349 total
Other
Jounce Therapeutics, Inc.
Common Stock
2020-11-11−1,000,000→ 9,230,349 total
Other
Revolution Medicines, Inc.$RVMD
Common Stock
2020-09-09−1,000,000→ 8,024,031 total
Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2020-07-28+4,508,333→ 5,383,333 total
Conversion
Nurix Therapeutics, Inc.$NRIX
Series A-2 Preferred Stock
2020-07-28−875,000→ 0 total
Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2020-07-28+39,216→ 5,422,549 total
Conversion
Nurix Therapeutics, Inc.$NRIX
Series B Preferred Stock
2020-07-28−4,508,333→ 0 total
Conversion
Nurix Therapeutics, Inc.$NRIX
Series D Preferred Stock
2020-07-28−39,216→ 0 total
Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2020-07-28+875,000→ 875,000 total
Conversion
Relay Therapeutics, Inc.$RLAY
Series A Convertible Preferred Stock
2020-07-20−9,920,455→ 0 total
Conversion
Relay Therapeutics, Inc.$RLAY
Common Stock
2020-07-20+17,427→ 2,811,197 total
Conversion
Relay Therapeutics, Inc.$RLAY
Series A Convertible Preferred Stock
2020-07-20−35,404,286→ 0 total
Conversion
Relay Therapeutics, Inc.$RLAY
Common Stock
2020-07-20+2,793,770→ 2,793,770 total
Conversion
Relay Therapeutics, Inc.$RLAY
Common Stock
2020-07-20+17,427→ 9,987,881 total
Conversion
Relay Therapeutics, Inc.$RLAY
Series B Convertible Preferred Stock
2020-07-20−61,881→ 0 total
Conversion
Relay Therapeutics, Inc.$RLAY
Common Stock
2020-07-20+9,970,454→ 9,970,454 total
Conversion
Relay Therapeutics, Inc.$RLAY
Series B Convertible Preferred Stock
2020-07-20−61,881→ 0 total

Companies

Recent Filings

Address

300 THIRD STREET

CAMBRIDGE, MA, 02142

View on SEC.gov